DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ocular Inflammation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report to their offering. Ocular Inflammation – Global API Manufacturers, Marke…
Open-Angle Glaucoma Report – Global API Manufacturers, Marketed and Phase III Drugs Landscape 2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Open-Angle Glaucoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016” report to their offering. Open-Angle Glaucoma – Global API Manufacturers, Marke…
Novartis reports $11.6 billion in net sales in first quarter
Novartis reported $11.6 billion in net sales in the first quarter compared with $11.9 billion in the same quarter of 2015, according to a press release. Net income was reported at $2 billion in the first quarter compared with $2.3 billion reported in t…
Valeant names Joseph C. Papa as new chairman, CEO
Valeant Pharmaceuticals International announced in a press release that its board of directors has named Joseph C. Papa as Valeant’s chairman and CEO.Papa, chairman and CEO of Perrigo Company plc, a global health care supplier that develops and distributes over-the-counter and prescription pharmaceuticals, is expected to begin his new position in early May, according to the release. He will succeed J. Michael Pearson, who is expected to remain as CEO and a director until Papa begins at Valeant, the release reported.
Make the Diagnosis: Eye Surprise
(MedPage Today) — Case Findings: A 35-year-old physician participating in Doctors Without Borders returned from a trip to Africa and developed localized pain and itching followed by arthritic pain and swelling that lasted for several weeks. He visited…
Rituximab used to treat recalcitrant noninfectious scleritis
Rituximab, with and without additional immunomodulatory therapy, resulted in steroid-free remission of recalcitrant noninfectious scleritis in a majority of patients in one study. The retrospective case series included 24 eyes of 15 patients with clini…